The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Alafair Biosciences sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Premium Insights Alafair Biosciences Inc, United States Revenue

Buy the Report

Premium Insights

The gold standard of business intelligence.

Find out more

Alafair Biosciences is a medical device company that develops and commercialize surgical products for soft tissue repair and protection applications. The company develops products based on a non-cell adhesive hydrogel technology to protect and manage advanced wound healing. It offers VersaWrap tendon protector, an ultrathin, sutureless, bioresorbable hydrogel that protects tendon gliding by separating injured tendon from surrounding tissues. Alafair Biosciences offers tendon protector, which is made of polysaccharides alginate and hyaluronic acid, and contains no animal derived components. The company’s product is used in procedures such as suture of tendon or tendon sheath, tenodesis, reattachment of tendon, tenolysis, repair of tendorn in hand, wrist and forearm, and other procedures of the hand or extremities. Alafair Biosciences is headquartered in Austin, Texas, the US.

The key metrics of Alafair Biosciences related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:

As Alafair Biosciences is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Alafair Biosciences.

For a detailed understanding of the performance of Alafair Biosciences, buy the report here.

Premium Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

GlobalData’s revenue report leverages GlobalData’s SKU tracker, which contains real-world, purchasing data from the US healthcare institutions.